Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
about
Meta-analysis of efficacy and safety of intravenous ferric carboxymaltose (Ferinject) from clinical trial reports and published trial dataThe role of ferric carboxymaltose in the treatment of iron deficiency anemia in patients with gastrointestinal diseaseSafety and efficacy of intravenous iron therapy in reducing requirement for allogeneic blood transfusion: systematic review and meta-analysis of randomised clinical trialsEfficacy and Safety of Ferric Carboxymaltose and Other Formulations in Iron-Deficient Patients: A Systematic Review and Network Meta-analysis of Randomised Controlled TrialsIntravenous iron therapy: how far have we come?Comparison of the renal, cardiovascular and hepatic toxicity data of original intravenous iron compounds.Ferric Carboxymaltose as Treatment in Women with Iron-Deficiency AnemiaThe pharmacokinetics and pharmacodynamics of iron preparations.Four weeks of IV iron supplementation reduces perceived fatigue and mood disturbance in distance runners.Cost-minimization analysis favours intravenous ferric carboxymaltose over ferric sucrose for the ambulatory treatment of severe iron deficiency.Treatment of iron deficiency with intravenous ferric carboxymaltose in general practice: a retrospective database study.Effectiveness and safety of ferric carboxymaltose treatment in children and adolescents with inflammatory bowel disease and other gastrointestinal diseases.Effect of ferric carboxymaltose on serum phosphate and C-terminal FGF23 levels in non-dialysis chronic kidney disease patients: post-hoc analysis of a prospective study.Intravenous iron isomaltoside 1000 administered by high single-dose infusions or standard medical care for the treatment of fatigue in women after postpartum haemorrhage: study protocol for a randomised controlled trial.Comparative evaluation of nephrotoxicity and management by macrophages of intravenous pharmaceutical iron formulations.The safety and efficacy of high dose ferric carboxymaltose in patients with chronic kidney disease: A single center studyIntravenous Iron Therapy in Patients with Iron Deficiency Anemia: Dosing Considerations.Economic evaluation of intravenous iron treatments in the management of anemia patients in GreeceSafety and Efficacy of Intravenous Ferric Carboxymaltose (750 mg) in the Treatment of Iron Deficiency Anemia: Two Randomized, Controlled Trials.Efficacy and safety of intravenous iron sucrose in treating adults with iron deficiency anemia.Intravenous ferric carboxymaltose for the treatment of iron deficiency anemia.Iron metabolism and iron supplementation in cancer patientsDiluting ferric carboxymaltose in sodium chloride infusion solution (0.9% w/v) in polypropylene bottles and bags: effects on chemical stability.Clinical experience with ferric carboxymaltose in the treatment of cancer- and chemotherapy-associated anaemiaClinical iron deficiency disturbs normal human responses to hypoxia.High-dose intravenous treatment in iron deficiency anaemia in inflammatory bowel disease: early efficacy and impact on quality of lifeDirect Comparison of the Safety and Efficacy of Ferric Carboxymaltose versus Iron Dextran in Patients with Iron Deficiency Anemia.Comparative efficacy and safety of intravenous ferric carboxymaltose (Ferinject) and iron(III) hydroxide dextran (Cosmofer) in pregnancyIntravenous iron in inflammatory bowel disease.Use of agents stimulating erythropoiesis in digestive diseasesExperience with intravenous ferric carboxymaltose in patients with iron deficiency anemiaTreatment of Iron Deficiency with or without Anaemia with Intravenous Ferric Carboxymaltose in Gynaecological Practices - A Non-Interventional Study.Postpartum anemia II: prevention and treatment.Comparative review of the safety and efficacy of ferric carboxymaltose versus standard medical care for the treatment of iron deficiency anemia in bariatric and gastric surgery patients.Current management of iron deficiency anemia in inflammatory bowel diseases: a practical guide.Anemia in chronic kidney disease patients: treatment recommendations and emerging therapies.Is iron treatment beneficial in, iron-deficient but non-anaemic (IDNA) endurance athletes? A systematic review and meta-analysis.Ferric carboxymaltose: a review of its use in iron deficiency.European consensus on the diagnosis and management of iron deficiency and anaemia in inflammatory bowel diseases.A multicenter, randomized, active-controlled study to investigate the efficacy and safety of intravenous ferric carboxymaltose in patients with iron deficiency anemia.
P2860
Q21261840-6CA725A5-2A4F-4C65-B3CC-1C08DB2CCBC4Q26771882-0EAD868A-D991-41FF-9C7C-EA97F73EFC13Q26829377-7B7AB808-A901-4A01-9D89-324B3F1159E5Q28085514-BF88DA0F-918D-4F90-AC3B-A8F29E81E2AFQ28276678-3D5642C5-81B3-41B1-8D95-0D60E171E996Q33583025-78FEB708-3803-4AEE-8D74-4C0BB3C98F09Q33607976-F392698C-D656-4C3B-870F-7EC29777B86BQ34039226-64214AE2-F321-45D7-8D12-073DB156B2ADQ34232381-A211E797-B5B1-4E9D-85A0-4EE33B7F4842Q34429565-FA424624-D2CC-468C-BFC5-03A899E42C00Q34443900-764C6EBD-043A-4F94-9C77-B3009EA2AB0AQ34867539-68DE32C2-E66A-4DB0-93E2-9A57335D80F1Q34884492-45AB142C-090F-43DD-9A5B-C3BBA0D60515Q35078212-3AD12BE2-466B-4CCD-ADB3-7AEB9BAB6498Q35631492-BDF6DE14-9847-4E20-BBC2-5694218AC07BQ35830277-FDA9EECA-0B4F-485F-B588-8FEA6D970501Q35898038-B4AEADBE-C50B-4A2A-8BEE-2E96DCDABF52Q35982607-300F00CD-2CA4-451C-9449-5314E4B68E37Q36241297-402CCE3D-D90F-43DD-A65E-920BEE2C63E2Q36283062-0C96E95D-A9BD-4558-A299-290C02224E10Q36371086-227DB757-0182-48E9-A99A-54FB8E9A4525Q36371665-E5D69EFE-4D09-415A-BA5B-BFEDCB66D2AEQ36475511-B3F43E62-F6F9-4B7A-857B-642EACD27448Q36551637-24847930-9AC7-4535-B866-99DD62465AE3Q36951774-48314045-E34F-4A11-B055-447FF30295D5Q37032277-51DBB4A7-87CA-4107-8B3E-5EE7EEC843F3Q37171855-82197603-C1A0-4060-A45E-833947C35111Q37186219-97461218-F3C6-4658-B7C2-F2B21194DAAAQ37368728-B8E87E31-8C2D-4B17-AFC7-A4808839A154Q37368733-7129996F-9444-4450-9FA5-86F2890D133DQ37629734-94D5B41B-FBC9-49A0-A98A-0D499BAC6690Q37660608-39A0557A-A082-4F35-8A6B-AC2473CCA16FQ37967367-D4BD1352-B2F8-46CE-9253-DE5DECE5F95DQ38095831-DDD0C9D2-EA90-4DDA-89F1-376891BF9DA6Q38151564-A35A69F8-12C4-4CD9-A260-6D5500D014E1Q38229636-93414736-0265-400A-8983-D6A9F37D6938Q38264186-E47062C6-76A8-4854-95A0-4E7136C7C42BQ38271890-4B56F6D7-E7E7-438E-A5C5-A9DD5BEEDB5BQ38291941-FFFBD090-1ADF-4F9C-B93A-94D2819FC65EQ38314781-FCF4A570-2F0B-4763-8C70-F4EAE8F1E2BA
P2860
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@en
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@nl
type
label
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@en
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@nl
altLabel
Ferric Carboxymaltose
@en
prefLabel
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@en
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@nl
P1433
P1476
Ferric carboxymaltose: a review of its use in iron-deficiency anaemia.
@en
P304
P356
10.2165/00003495-200969060-00007
P577
2009-01-01T00:00:00Z
P6179
1030925487